US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist
  • 1.600
  • +0.010+0.63%
Close Nov 27 16:00 ET
  • 1.600
  • 0.0000.00%
Post 20:01 ET
82.80MMarket Cap-1600P/E (TTM)

PMV Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PMV Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

PMV Pharmaceuticals Earnings Reports

  • PMV Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 08:03 ET

  • PMV Pharmaceuticals | 8-K: PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results

    Nov 7 08:03 ET

  • PMV Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:04 ET

  • PMV Pharmaceuticals | 8-K: PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial

    Aug 8 08:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 20, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data